Clarithromycin clinical pharmacokinetics (Q40772744)

23 September 2017

1 reference

title

Clarithromycin clinical pharmacokinetics (English)

1 reference

23 September 2017

1 reference

1 reference

F Fraschini

1

1 reference

23 September 2017

F Scaglione

series ordinal

2

1 reference

23 September 2017

G Demartini

series ordinal

3

1 reference

23 September 2017

1 September 1993

1 reference

Clinical Pharmacokinetics

23 September 2017

1 reference

23 September 2017

25

1 reference

23 September 2017

189-204

1 reference

23 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199325030-00003

23 September 2017

0 references

cites work

In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin

1 reference

12 December 2020

In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide

1 reference

12 December 2020

Clarithromycin pharmacokinetics in healthy young and elderly volunteers

1 reference

12 December 2020

Clinical efficacy and tolerance of two new macrolides, clarithromycin and josamycin, in the treatment of patients with acute exacerbations of chronic bronchitis.

1 reference

12 December 2020

Pharmacokinetics of a clarithromycin suspension in infants and children

1 reference

12 December 2020

[Clinical evaluation of clarithromycin in treatment of acute dental infections. Comparative double-blind study using josamycin as the control].

1 reference

12 December 2020

Efficacy and safety of clarithromycin versus josamycin in the treatment of hospitalized patients with bacterial pneumonia

1 reference

12 December 2020

Comparative pharmacokinetics of clarithromycin (TE-031), a new macrolide antibiotic, and erythromycin in rats

1 reference

12 December 2020

Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans

1 reference

12 December 2020

Comparison of the clinical and bacteriological efficacy of clarithromycin and erythromycin in the treatment of streptococcal pharyngitis

1 reference

12 December 2020

[Clinical study of clarithromycin, a new macrolide antibiotic, in children].

1 reference

12 December 2020

The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil and lung in humans

1 reference

12 December 2020

Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis

1 reference

12 December 2020

Multiplicity of steroid-inducible cytochromes P-450 in rat liver microsomes

1 reference

12 December 2020

The in-vitro activity and disc susceptibility testing of clarithromycin and its 14-hydroxy metabolite

1 reference

12 December 2020

Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive‐drug interactions with anticonvulsants and antibiotics

1 reference

12 December 2020

Susceptibility testing of macrolide antibiotics against Haemophilus influenzae and correlation of in vitro results with in vivo efficacy in a mouse septicemia model

1 reference

12 December 2020

Cellular uptake and subcellular distribution of roxithromycin and erythromycin in phagocytic cells

1 reference

12 December 2020

Comparative in vitro potencies of nine new macrolides.

1 reference

12 December 2020

Absolute bioavailability of clarithromycin after oral administration in humans

1 reference

12 December 2020

An in-vitro evaluation of the cellular uptake and intraphagocytic bioactivity of clarithromycin (A-56268, TE-031), a new macrolide antimicrobial agent

1 reference

12 December 2020

In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms

1 reference

12 December 2020

Treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing clarithromycin with erythromycin. Canada-Sweden Clarithromycin-Pneumonia Study Group

1 reference

12 December 2020

Autobacteriographic studies of clarithromycin and erythromycin in mice

1 reference

12 December 2020

In-vitro activity of LY146032 daptomycin and other agents against JK diphtheroids

1 reference

12 December 2020

Measurement of pulmonary erythromycin concentration in patients with lobar pneumonia by means of positron tomography

1 reference

12 December 2020

In vitro activity of A-56268 (TE-031), a new macrolide antibiotic, compared with that of erythromycin and other antimicrobial agents

1 reference

12 December 2020

Self-induction by erythromycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450.

1 reference

12 December 2020

The tropism of erythromycin for the respiratory system

1 reference

12 December 2020

Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions

1 reference

12 December 2020

Hypoactivity of cytochrome P-450 after triacetyloleandomycin administration

1 reference

12 December 2020

Comparative in vitro activity of A-56268.

1 reference

12 December 2020

Identification of the cytochrome P-450 induced by macrolide antibiotics in rat liver as the glucocorticoid responsive cytochrome P-450p

1 reference

12 December 2020

New macrolides active against Streptococcus pyogenes with inducible or constitutive type of macrolide-lincosamide-streptogramin B resistance

1 reference

12 December 2020

Comparative in vitro activity of A-56268 (TE-031) against gram-positive and gram-negative bacteria and Chlamydia trachomatis

1 reference

12 December 2020

In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex

1 reference

12 December 2020

In-vitro activity of clarithromycin (A-56268; TE-031) against gram-positive bacteria

1 reference

12 December 2020

Simultaneous determination of clarithromycin and 14(R)-hydroxyclarithromycin in plasma and urine using high-performance liquid chromatography with electrochemical detection

1 reference

12 December 2020

Comparative in-vitro activities of A-56268 (TE-031) and erythromycin against 306 clinical isolates.

1 reference

12 December 2020

Variability of clarithromycin and erythromycin susceptibility tests with Haemophilus influenzae in four different broth media and correlation with the standard disk diffusion test

1 reference

12 December 2020

The in-vitro activity of clarithromycin and other macrolides against the type strain of Chlamydia pneumoniae (TWAR)

1 reference

12 December 2020

Activity of antibiotics against pigmented and unpigmented variants of Mycobacterium avium-intracellulare

1 reference

12 December 2020

Safety and efficacy of Clarithromycin in the treatment of acute mild to moderate respiratory tract infections

1 reference

12 December 2020

Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides

1 reference

12 December 2020

Antibiotic entry into human polymorphonuclear leukocytes

1 reference

12 December 2020

Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides

1 reference

12 December 2020

Comparative in vitro activity of A-56268 (TE-031), a new macrolide antibiotic.

1 reference

12 December 2020

The pharmacokinetics of clarithromycin and its 14-OH metabolite

1 reference

12 December 2020

Drug-food interaction potential of clarithromycin, a new macrolide antimicrobial

1 reference

12 December 2020

Effects of erythromycin on hepatic drug-metabolizing enzymes in humans

1 reference

12 December 2020

Pharmacokinetics of clarithromycin granule and tablet in children

1 reference

12 December 2020

Synergy between RU 28965 (roxithromycin) and human neutrophils for bactericidal activity in vitro

1 reference

12 December 2020

Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part I).

1 reference

12 December 2020

Self-induction by oleandomycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450. Comparison with troleandomycin

1 reference

12 December 2020

An in-vitro comparison of the intraphagocytic bioactivity of erythromycin and roxithromycin.

1 reference

12 December 2020

Comparative in vitro activity, serum binding and binding activity interactions of the macrolides A-56268, RU-28965, erythromycin and josamycin.

1 reference

12 December 2020

Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin

1 reference

12 December 2020

Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses

1 reference

12 December 2020

14-Hydroxy-6-O-methylerythromycins A, active metabolites of 6-O-methylerythromycin A in human

1 reference

12 December 2020

Formation of inactive cytochrome P-450 Fe(II)-metabolite complexes with several erythromycin derivatives but not with josamycin and midecamycin in rats.

1 reference

12 December 2020

In vitro and in vivo activities of clarithromycin against Mycobacterium avium

1 reference

12 December 2020

Uptake of clarithromycin by rat lung cells

1 reference

12 December 2020

Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial

1 reference

12 December 2020

Activity of A-56268 compared with that of erythromycin and other oral agents against aerobic and anaerobic bacteria

1 reference

12 December 2020

Metabolism and disposition of clarithromycin in man.

1 reference

12 December 2020

Comparative in-vitro activity of A-56268 (TE-031), a new macrolide antibiotic

1 reference

12 December 2020

Self-induction by triacetyloleandomycin of its own transformation into a metabolite forming a stable 456 nm-absorbing complex with cytochrome P-450

1 reference

12 December 2020

Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential

1 reference

12 December 2020

In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis

1 reference

12 December 2020

Comparative inhibitory and bactericidal activities of FCE 22101 against gram-positive cocci and anaerobes in vitro

1 reference

12 December 2020

10.2165/00003088-199325030-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

23 September 2017

0 references

1 reference